Therapy Flashcards

(45 cards)

1
Q

anticoagulant

A

drug that works by either 1) inhibiting thrombin or factor Xa or 2) decreasing the level of competent clotting factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

fibrinolytic agents

A

drugs that accelerate degradation of existing fibrin clots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

antiplatelet agents

A

drugs that inhibit platelet plug formation by inhibiting platelet activation or preventing platelets from sticking to each other

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

examples of anticoagulants

A

unfractionated heparin, low molecular weight heparin, direct inhibitors of thrombin/factor X, coumadin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

unfractionated heparin activity

A

a proteoglycan that indirectly inactivates serine proteases (2,10, 9, 11, 12) by binding to antithrombin and enhancing its activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

where is heparin synthesized?

A

mast cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

difference between unfractionated heparin and LMW heparin?

A

LMWH isn’t long enough to bind both antithrombin and thrombin. LMWH can only inhibit Xa, not thrombin –> so doesn’t increase aPTT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how is unfractionated heparin administered?

A

IV or SubQ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

half life of unfractionated heparin

A

short (1hr)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

indications for unfractionated heparin use

A

treatment of acute arterial and venous thromboembolism, prevention of thromboembolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

time span of unfractionated heparin effects

A

works immediately

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

toxicities associated with unfractionated heparin

A

bleeding, osteoporosis, thrombocytopenia, thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

heparin induced throbocytopenia with thrombosis (HIT)

A

causes thrombocytopenia and microvascular thrombosis (arterial and venule) in patients on heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

mechanism of HIT

A

antibodies recognize the heparin/PF4 complex, which triggers platelet activation and clumping which leads to occlusion and thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how to treat HIT?

A

stop the heparin! give a different thrombin inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

consequence of being put on heparin after having had HIT?

A

rapid onset of thrombocytopenia due to antibody memory response (24hrs rather than 5-10 days)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how to monitor unfractionated heparin levels

A

aPTT should be only 1.5-2x normal. and heparin assay should only be 0.2-0.4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

low molecular weight heparin (LMWH)

A

unfractionated heparin that has been processed to only include molecules of a specific, smaller size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

advantages of LMWH compared to UFH

A

longer half life, less bleeding and thrombocytopenia, but unfortunately is more expensive

20
Q

intravenous direct thrombin inhibitors

A

lepirudin & argatroban. given to patients with HIT, work immediately, can cause bleeding, very expensive

21
Q

lepirudin

A

recombinant modified hirudin (leech spit), treats HIT, excreted renally

22
Q

argatroban

A

derivative of arginine, treats HIT, hepatic excretion (not for use in liver failure patients)

23
Q

orally administered direct thrombin inhibitor

24
Q

factor Xa inhibitors

A

fondaparinux, apixaban, rivaroxaban, edoxaban

25
fondaparinux
smallest subunit of heparin side chain, so can only inhibit factor 10a. given IV/SQ
26
apixaban, rivaroxaban, edoxaban
orally administered factor 10a inhibitor
27
which drugs inhibit factor X?
LMWH, rivaroxaban, apixaban, fondaparinux, UFH
28
which drugs inhibit thrombin?
UFH, dabigatran
29
warfarin
prevents formation of thrombin by sequestering vitamin K in epoxide form. therefore decreases the synthesis of 2,7,9,10,C/S
30
where do we get vitamin k?
green leafy vegetables, gut flora, stored in liver
31
warfarin metabolism pathway
travels from gut to blood, where is is bound by albumin. free warfarin gets transported to liver where it is activated
32
indications for coumadin use
venous/arterial thromboses recurrence prevention, atrial fibrillation/prosthetic valve clot prevention
33
how to monitor coumadin levels
increased PT via INR (internationalized normalized ratio). higher indicates greater bleeding risk/lower indicates clotting risk (narrow therapeutic window!)
34
warfarin toxicity
risk of bleeding, embryopathy, coumadin induced skin necrosis
35
how do you treat someone on warfarin who is actively bleeding/
give vitamin k and fresh frozen plasma
36
examples of fibrinolytic agents
strokinase, urokinase, tissue type plasminogen activator (tPA)
37
action of fibrinolytic agents
increase plasminogen cleavage to plasmin
38
post phlebitic syndrome
DVT stints veins and sets off inflammatory response, veins never return to normal and risk of developing stasis is higher, setting patient up for another event. chronic local inflammation and swelling
39
standard of care for venous thrombosis
UFH or LMWH followed by coumadin, which is maintained for 3-6 mos
40
three types of antiplatelets
receptor antagonists, signal blockers, integrin blockers
41
clopidogrel (plavex)
antiplatelet agent via ADPY12 receptor blockage.
42
aspirin
antiplatelet agent via signal blocking within platelets (irreversible COX1 inhibition so that TxA2 can't be synthesized)
43
anti platelet integrin blockers
ReoPro, Integrilin, Tirofiban
44
how big is UFH?
varying sizes due to variations in GAG chain length
45
why is LMWH supplanting UFH?
longer half life (less frequent administration), more predictable kinetics (less monitoring), reduced cause of thrombocytopenia